Lentiviral Vector Production and Quantification
Corresponding Organization : University of South Carolina
Variable analysis
- Lentiviral construct (HIV-1 NL4-3, NLENY1, and YU-2)
- Envelope protein (native HIV-1 envelope or VSV-G envelope)
- Viral packaging efficiency
- P24 antigen levels in viral stocks
- Amount of lentiviral construct DNA used (10–17 µg)
- Amount of VSV-G plasmid DNA used (3–4 µg)
- Transfection method (Lipofectamine plus or Lipofectamine-2000)
- Incubation time (16 h after transfection)
- Washing and medium change after transfection
- Centrifugation and filtration of culture supernatants
- Addition of MgCl2 (4 mM) and RNase-free DNase treatment of viral stocks
- Storage of viral stocks at -80°C
- Viral inoculum concentration (50–1,000 ng/mL) used to infect cells
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!